Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-187-3 | CAS number: 79-22-1
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
Methyl chloroformate was tested in the pre incubation assay according to OECD TG 471 with and without metabolic activation in S.typhimuriumTA98, TA100, TA1535 and TA1537 at dose levels of 5 -5000 µg /plate. No increase in the number of revertants was detected in any strain with and without metabolic activation. Vehicle controls and positive controls were valid. Cytotoxicity was observed (concentrations not stated). Methylchloroformate was not mutagenic in this assay (BASF AG, 1988).
Methylchloroformate was tested for chromosomal aberrations in a study comparable to OECD TG 473, with V79 cells at concentrations of 0.1, 1.0, 2.5 µl/mL. Positive and negative controls reacted appropriately. Cytotoxicity was observed (concentration not stated). Under the conditions described in this report, there was an unequivocal enhancement of the aberration rates 7 h and 28 h after the treatment of the cells with 2.5 µ1/ml in the presence of metabolic activation but the results were negative after 18 hours. No chromosomal aberrations were observed in the absence of metabolic activation. Methylchloroformate is considered ambigous for chromosomal aberrations in the presence of metabolic activation (LMP, 1986).
Short description of key information:
Methylchloroformate was not mutagenic in the Ames test. Ambiguous results were obtain in a chromosomal aberration as positive and negative results for chromosomal aberrations in the presence of metabolic activation. Ambiguous results are assumed to be due to cytotoxicity and/or deliberation of hydrochloric acid of methylchloroformate in the test system..
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
No classification concerning repeated dose toxicity is warranted according to EU Regulation 67/548 and EU Regulation 1272/2008 as classification criteria are not met.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
